A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
NCT02522312 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102
Last updated 2016-03-03
Summary
A retrospective analysis of Restasis® benefits in dry eye contact lens patients.
Conditions
- Dry Eye Syndrome
Interventions
- OTHER
-
No Intervention
No drug is administered in this study
Sponsors & Collaborators
-
Hazleton Eye Specialists
lead OTHER
Principal Investigators
-
Thomas P Kislan, Dr. · Owner
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease
NCT03597139 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
NCT01198782 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
NCT00399061 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax
NCT04555694 ·Status: COMPLETED ·Phase: PHASE4
-
Switching From Restasis to TRYPTYR
NCT07267299 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Natural History Study of Patients With Dry Eye
NCT00833235 ·Status: COMPLETED
-
Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT02917512 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
NCT02013791 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of HE10 for Dry Eye Syndrome
NCT02492412 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Use of Restasis and PROSE Devices
NCT04735510 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
NCT02028312 ·Status: WITHDRAWN ·Phase: PHASE4
-
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
NCT03492541 ·Status: COMPLETED ·Phase: NA
-
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
NCT00407043 ·Status: COMPLETED ·Phase: PHASE4
-
Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE Device
NCT04918823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 ·Status: COMPLETED ·Phase: NA
-
Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
NCT00345241 ·Status: COMPLETED ·Phase: NA
-
Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
NCT02121847 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
NCT01072526 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation
NCT02910713 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual Occlusion
NCT04022382 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms
NCT00405457 ·Status: COMPLETED ·Phase: PHASE4
-
Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)
NCT01817582 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients
NCT00611403 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2